Shares Outstanding Shares Outstanding n/a Close	32.14M
Shares Change (YoY) Shares Change (YoY) n/a Close	-3.76%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	-2.37%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	99.99%
Shares Floating Shares Floating n/a Close	30.79M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	53
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.02%

Short Selling Information

The latest short interest is 4.82M, so 14.98% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	4.82M
Short % of Shares Out Short % of Shares Out n/a Close	14.98%
Short % of Float Short % of Float n/a Close	17.88%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	17.94

Valuation Ratios

The PE ratio is 13.36 and the forward PE ratio is 4.27. Collegium Pharmaceutical's PEG ratio is 0.4.

PE Ratio PE Ratio n/a Close	13.36
Forward PE Forward PE n/a Close	4.27
PS Ratio PS Ratio n/a Close	1.46
Forward PS Forward PS n/a Close	1.3
PB Ratio PB Ratio n/a Close	4.04
P/FCF Ratio P/FCF Ratio n/a Close	4.55
PEG Ratio PEG Ratio n/a Close	0.4

Financial Ratio History

Enterprise Valuation

Collegium Pharmaceutical has an Enterprise Value (EV) of 1.71B.

EV / Sales EV / Sales n/a Close	2.71
EV / EBITDA EV / EBITDA n/a Close	5.01
EV / EBIT EV / EBIT n/a Close	8.36
EV / FCF EV / FCF n/a Close	8.43

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 3.75.

Current Ratio Current Ratio n/a Close	0.95
Quick Ratio Quick Ratio n/a Close	0.88
Debt / Equity Debt / Equity n/a Close	3.75
Debt / EBITDA Debt / EBITDA n/a Close	2.51
Debt / FCF Debt / FCF n/a Close	4.23
Interest Coverage Interest Coverage n/a Close	2.3

Financial Efficiency

Return on Equity is 30.23% and Return on Invested Capital is 9.77%.

Return on Equity Return on Equity n/a Close	30.23%
Return on Assets Return on Assets n/a Close	4.16%
Return on Invested Capital Return on Invested Capital n/a Close	9.77%
Revenue Per Employee Revenue Per Employee n/a Close	$1,768,764.71
Profits Per Employee Profits Per Employee n/a Close	$193,809.52
Employee Count Employee Count n/a Close	357
Asset Turnover Asset Turnover n/a Close	0.38
Inventory Turnover Inventory Turnover n/a Close	7.15

Taxes

Income Tax Income Tax n/a Close	29.38M
Effective Tax Rate Effective Tax Rate n/a Close	29.8%

Stock Price Statistics

The stock price has increased by -6.99% in the last 52 weeks. The beta is 0.65, so Collegium Pharmaceutical's price volatility has been higher than the market average.

Beta Beta n/a Close	0.65
52-Week Price Change 52-Week Price Change n/a Close	-6.99%
50-Day Moving Average 50-Day Moving Average n/a Close	28.77
200-Day Moving Average 200-Day Moving Average n/a Close	31.28
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	55.59
Average Volume (20 Days) Average Volume (20 Days) n/a Close	328,332

Income Statement

In the last 12 months, Collegium Pharmaceutical had revenue of 631.45M and earned 69.19M in profits. Earnings per share was 2.14.

Revenue Revenue n/a Close	631.45M
Gross Profit Gross Profit n/a Close	377.34M
Operating Income Operating Income n/a Close	169.9M
Net Income Net Income n/a Close	69.19M
EBITDA EBITDA n/a Close	341.7M
EBIT EBIT n/a Close	172.54M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	2.14

Full Income Statement

Balance Sheet

The company has 70.56M in cash and 859.3M in debt, giving a net cash position of -788.73M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	70.56M
Total Debt Total Debt n/a Close	859.3M
Net Cash Net Cash n/a Close	-788.73M
Retained Earnings Retained Earnings n/a Close	-164M
Total Assets Total Assets n/a Close	1.63B
Working Capital Working Capital n/a Close	40.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 204.98M and capital expenditures -1.65M, giving a free cash flow of 203.33M.

Operating Cash Flow Operating Cash Flow n/a Close	204.98M
Capital Expenditures Capital Expenditures n/a Close	-1.65M
Free Cash Flow Free Cash Flow n/a Close	203.33M
FCF Per Share FCF Per Share n/a Close	6.3

Full Cash Flow Statement

Margins

Gross margin is 59.76%, with operating and profit margins of 26.91% and 10.96%.

Gross Margin Gross Margin n/a Close	59.76%
Operating Margin Operating Margin n/a Close	26.91%
Pretax Margin Pretax Margin n/a Close	15.61%
Profit Margin Profit Margin n/a Close	10.96%
EBITDA Margin EBITDA Margin n/a Close	54.11%
EBIT Margin EBIT Margin n/a Close	26.91%
FCF Margin FCF Margin n/a Close	32.2%

Dividends & Yields

COLL does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	7.48%
FCF Yield FCF Yield n/a Close	21.99%

Dividend Details

Analyst Forecast

The average price target for COLL is $44, which is 46.9% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$44
Price Target Difference Price Target Difference n/a Close	46.9%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$47.87
Lynch Upside Lynch Upside n/a Close	59.83%
Graham Number Graham Number n/a Close	18.49
Graham Upside Graham Upside n/a Close	-38.26%

Scores

Altman Z-Score Altman Z-Score n/a Close	0.99
Piotroski F-Score Piotroski F-Score n/a Close	5